trichostatin A

Trichostatin is a lipid of Polyketides (PK) class. Trichostatin is associated with abnormalities such as Dentatorubral-Pallidoluysian Atrophy, PARAGANGLIOMAS 3, abnormal fragmented structure, Disintegration (morphologic abnormality) and Hyperostosis, Diffuse Idiopathic Skeletal. The involved functions are known as Acetylation, Cell Differentiation process, histone modification, Gene Silencing and Transcriptional Activation. Trichostatin often locates in CD41a, Hematopoietic System, Chromatin Structure, Blood and Endothelium. The associated genes with Trichostatin are SPI1 gene, CELL Gene, Chromatin, CXCR4 gene and DNMT1 gene. The related lipids are Butyrates, Promega, butyrate, Lipopolysaccharides and Steroids. The related experimental models are Knock-out, Mouse Model, Xenograft Model and Cancer Model.

Cross Reference

Introduction

To understand associated biological information of trichostatin A, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with trichostatin A?

trichostatin A is suspected in Infection, Morphologically altered structure, Ureteral obstruction, Photosensitization, Atherosclerosis, Hypertrophic Cardiomyopathy and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with trichostatin A

MeSH term MeSH ID Detail
Chondrosarcoma D002813 9 associated lipids
Cell Transformation, Viral D002472 26 associated lipids
Cell Transformation, Neoplastic D002471 126 associated lipids
Cat Diseases D002371 12 associated lipids
Carcinoma, Renal Cell D002292 12 associated lipids
Carcinoma, Non-Small-Cell Lung D002289 72 associated lipids
Carcinoma D002277 18 associated lipids
Breast Neoplasms D001943 24 associated lipids
Brain Neoplasms D001932 15 associated lipids
Body Weight D001835 333 associated lipids
Per page 10 20 50 100 | Total 139

PubChem Associated disorders and diseases

What pathways are associated with trichostatin A

Lipid pathways are not clear in current pathway databases. We organized associated pathways with trichostatin A through full-text articles, including metabolic pathways or pathways of biological mechanisms.

Related references are published most in these journals:

Pathway name Related literatures
Loading... please refresh the page if content is not showing up.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with trichostatin A?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with trichostatin A?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with trichostatin A?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with trichostatin A?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with trichostatin A?

Mouse Model

Mouse Model are used in the study 'Regulation of minichromosome maintenance gene family by microRNA-1296 and genistein in prostate cancer.' (Majid S et al., 2010), Mouse Model are used in the study 'Reversal of hypermethylation and reactivation of p16INK4a, RARbeta, and MGMT genes by genistein and other isoflavones from soy.' (Fang MZ et al., 2005) and Mouse Model are used in the study 'Histone deacetylase 3 mediates allergic skin inflammation by regulating expression of MCP1 protein.' (Kim Y et al., 2012).

Xenograft Model

Xenograft Model are used in the study 'Histone deacetylase inhibitors induce growth arrest and differentiation in uveal melanoma.' (Landreville S et al., 2012), Xenograft Model are used in the study 'Extended treatment with physiologic concentrations of dietary phytochemicals results in altered gene expression, reduced growth, and apoptosis of cancer cells.' (Moiseeva EP et al., 2007) and Xenograft Model are used in the study 'Retinoic acid and the histone deacetylase inhibitor trichostatin a inhibit the proliferation of human renal cell carcinoma in a xenograft tumor model.' (Touma SE et al., 2005).

Cancer Model

Cancer Model are used in the study 'Plasma pharmacokinetics and metabolism of the histone deacetylase inhibitor trichostatin a after intraperitoneal administration to mice.' (Sanderson L et al., 2004).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with trichostatin A

Download all related citations
Per page 10 20 50 100 | Total 3126
Authors Title Published Journal PubMed Link
Lu HK et al. Ex vivo response to histone deacetylase (HDAC) inhibitors of the HIV long terminal repeat (LTR) derived from HIV-infected patients on antiretroviral therapy. 2014 PLoS ONE pmid:25409334
Yang W et al. Effect of trichostatin A on gelsolin levels, proteolysis of amyloid precursor protein, and amyloid beta-protein load in the brain of transgenic mouse model of Alzheimer's disease. 2014 Curr Alzheimer Res pmid:25387339
Ying H et al. Pressure overload-induced cardiac hypertrophy response requires janus kinase 2-histone deacetylase 2 signaling. 2014 Int J Mol Sci pmid:25380525
Wu TH et al. Melatonin prevents neonatal dexamethasone induced programmed hypertension: histone deacetylase inhibition. 2014 J. Steroid Biochem. Mol. Biol. pmid:25090636
Shi Q et al. [Inhibitory effect of trichostatin A on HepG2 cell proliferation and the mechanisms]. 2014 Nan Fang Yi Ke Da Xue Xue Bao pmid:25057056
Tsuji M et al. Epigenetic regulation of resistance to emotional stress: possible involvement of 5-HT1A receptor-mediated histone acetylation. 2014 J. Pharmacol. Sci. pmid:25048113
Huan YJ et al. Epigenetic modification agents improve genomic methylation reprogramming in porcine cloned embryos. 2014 J. Reprod. Dev. pmid:25047549
Sun G et al. Insights into the lysine acetylproteome of human sperm. 2014 J Proteomics pmid:25038526
Poljak M et al. Class I to III histone deacetylases differentially regulate inflammation-induced matrix metalloproteinase 9 expression in primary amnion cells. 2014 Reprod Sci pmid:24429678
Unland R et al. Epigenetic repression of the dopamine receptor D4 in pediatric tumors of the central nervous system. 2014 J. Neurooncol. pmid:24264533
Sun DF et al. Inhibition of mTOR signalling potentiates the effects of trichostatin A in human gastric cancer cell lines by promoting histone acetylation. 2014 Cell Biol. Int. pmid:24030871
Smirnova L et al. MicroRNA profiling as tool for in vitro developmental neurotoxicity testing: the case of sodium valproate. 2014 PLoS ONE pmid:24896083
Soler E and Grosveld F Targeting epigenetics to speed up repair. 2014 Cell Stem Cell pmid:24792110
Poplutz MK et al. Regulation of the Interleukin-6 gene expression during monocytic differentiation of HL-60 cells by chromatin remodeling and methylation. 2014 Immunobiology pmid:24746556
Rafehi H et al. Vascular histone deacetylation by pharmacological HDAC inhibition. 2014 Genome Res. pmid:24732587
Hassan MK et al. Histone deacetylase inhibitors sensitize lung cancer cells to hyperthermia: involvement of Ku70/SirT-1 in thermo-protection. 2014 PLoS ONE pmid:24728004
Xu S et al. Cytostatic and apoptotic effects of DNMT and HDAC inhibitors in endometrial cancer cells. 2014 Curr. Pharm. Des. pmid:23888960
Jin YX et al. Histone deacetylase inhibitor trichostatin A affects porcine oocyte maturation in vitro. 2014 Reprod. Fertil. Dev. pmid:23759302
Sathe A et al. MicroRNA let-7f: a novel regulator of innate immune response in human endocervical cells. 2014 Am. J. Reprod. Immunol. pmid:24405266
Varol N et al. The epigenetically regulated effects of Wnt antagonists on the expression of genes in the apoptosis pathway in human bladder cancer cell line (T24). 2014 DNA Cell Biol. pmid:24665856
Wisnieski F et al. Differential expression of histone deacetylase and acetyltransferase genes in gastric cancer and their modulation by trichostatin A. 2014 Tumour Biol. pmid:24668547
Yan YE et al. Prenatal nicotinic exposure suppresses fetal adrenal steroidogenesis via steroidogenic factor 1 (SF-1) deacetylation. 2014 Toxicol. Appl. Pharmacol. pmid:24709674
Cherry KE et al. Identification of Tf1 integration events in S. pombe under nonselective conditions. 2014 Gene pmid:24680781
Karki P et al. Yin Yang 1 is a repressor of glutamate transporter EAAT2, and it mediates manganese-induced decrease of EAAT2 expression in astrocytes. 2014 Mol. Cell. Biol. pmid:24469401
Holownia A et al. Histone acetylation and arachidonic acid cytotoxicity in HepG2 cells overexpressing CYP2E1. 2014 Naunyn Schmiedebergs Arch. Pharmacol. pmid:24287576
Green BB and Kerr DE Epigenetic contribution to individual variation in response to lipopolysaccharide in bovine dermal fibroblasts. 2014 Vet. Immunol. Immunopathol. pmid:24268632
Ooi JY et al. HDAC inhibition attenuates cardiac hypertrophy by acetylation and deacetylation of target genes. 2015 Epigenetics pmid:25941940
Marquardt JU et al. Curcumin effectively inhibits oncogenic NF-κB signaling and restrains stemness features in liver cancer. 2015 J. Hepatol. pmid:25937435
Han Y et al. Murine hematopoietic stem cell dormancy controlled by induction of a novel short form of PSF1 by histone deacetylase inhibitors. 2015 Exp. Cell Res. pmid:25933513
Mishra DR et al. Identification of Critical Elements for Regulation of Inorganic Pyrophosphatase (PPA1) in MCF7 Breast Cancer Cells. 2015 PLoS ONE pmid:25923237
Zhao W et al. A traditional Chinese medicine, Lujiao prescription, as a potential therapy for hypertrophic cardiomyocytes by acting on histone acetylation. 2015 J Chin Med Assoc pmid:25913212
Lin S et al. IL-4 Modulates Macrophage Polarization in Ankylosing Spondylitis. 2015 Cell. Physiol. Biochem. pmid:25896783
Di Zanni E et al. Identification of novel pathways and molecules able to down-regulate PHOX2B gene expression by in vitro drug screening approaches in neuroblastoma cells. 2015 Exp. Cell Res. pmid:25882494
Martini M et al. Postmitotic Expression of SOD1(G93A) Gene Affects the Identity of Myogenic Cells and Inhibits Myoblasts Differentiation. 2015 Mediators Inflamm. pmid:26491230
Wang P et al. Epigenetic Changes are Associated with Programmed Cell Death Induced by Heat Stress in Seedling Leaves of Zea mays. 2015 Plant Cell Physiol. pmid:25670712
Mizutani E et al. Generation of cloned mice from adult neurons by direct nuclear transfer. 2015 Biol. Reprod. pmid:25653280
Ma J et al. Trichostatin A, a histone deacetylase inhibitor, suppresses proliferation and promotes apoptosis of esophageal squamous cell lines. 2015 Mol Med Rep pmid:25634603
Shah S et al. Impact of viral activators and epigenetic regulators on HIV-1 LTRs containing naturally occurring single nucleotide polymorphisms. 2015 Biomed Res Int pmid:25629043
Zhang Q et al. Trichostatin A Protects Against Experimental Acute-on-Chronic Liver Failure in Rats Through Regulating the Acetylation of Nuclear Factor-κB. 2015 Inflammation pmid:25604312
Li PT et al. Increased Histone Deacetylase Activity Involved in the Suppressed Invasion of Cancer Cells Survived from ALA-Mediated Photodynamic Treatment. 2015 Int J Mol Sci pmid:26473836
Hao ZF et al. Activating transcription factor 3 interferes with p21 activation in histone deacetylase inhibitor-induced growth inhibition of epidermoid carcinoma cells. 2015 Tumour Biol. pmid:25371069
Saraf S et al. Ex vivo expansion of human mobilized peripheral blood stem cells using epigenetic modifiers. 2015 Transfusion pmid:25363624
Nakada Y et al. Inhibitory effects of trichostatin A on adrenocorticotropic hormone production and proliferation of corticotroph tumor AtT-20 cells. 2015 Endocr. J. pmid:26497760
Uchida H and Ito S Differential regulation of expression of RNA-editing enzymes, ADAR1 and ADAR2, by 5-aza-2'-deoxycytidine and trichostatin A in human neuronal SH-SY5Y cells. 2015 Neuroreport pmid:26485095
Barr MP et al. VEGF-mediated cell survival in non-small-cell lung cancer: implications for epigenetic targeting of VEGF receptors as a therapeutic approach. 2015 Epigenomics pmid:26479311
Suo H et al. NRSF is an essential mediator for the neuroprotection of trichostatin A in the MPTP mouse model of Parkinson's disease. 2015 Neuropharmacology pmid:26188143
Gutiérrez J et al. Human papillomavirus type 16 E7 oncoprotein upregulates the retinoic acid receptor-beta expression in cervical cancer cell lines and K14E7 transgenic mice. 2015 Mol. Cell. Biochem. pmid:26173416
Hedberg Oldfors C et al. Analysis of an independent tumor suppressor locus telomeric to Tp53 suggested Inpp5k and Myo1c as novel tumor suppressor gene candidates in this region. 2015 BMC Genet. pmid:26170120
Ji S et al. [Association of irradiation-induced hippocampal neurogenesis impairment with histone H3 acetylation]. 2015 Zhonghua Yi Xue Za Zhi pmid:26168675
Liao HF et al. Dnmt3l-knockout donor cells improve somatic cell nuclear transfer reprogramming efficiency. 2015 Reproduction pmid:26159833